摘要
有关脂肪组织的研究调查几十年来关注于其“储存”功能。最新证据揭示脂肪组织作为一个内分泌器官释放一系列称为脂肪因子的介质。脂肪因子的介导功能包括生理和病理作用,如调节能量代谢、免疫反应和血管内平衡以及炎症和代谢疾病(即动脉粥样硬化、糖尿病和代谢综合征概念中的肥胖)。脂肪因子水平失调已被证实是这些潜在疾病的可能共同病理机理。例如,促炎和抗炎脂肪因子之间的不平衡与肥胖、糖尿病和动脉粥样硬化等疾病中的传统危险因素 (血脂异常、高血压、胰岛素抵抗) 呈正相关。脂肪因子介导的生物活性尤其影响内皮功能障碍/激活和斑块内炎症/易损性。本综述的目的是概述脂肪因子在动脉粥样硬化形成中的作用。讨论基础研究中关于脂肪因子诱导的血管和免疫细胞亚群的调控机制和证据。最后,我们将报道与临床试验相矛盾的结果,并试图使我们更好地理解为什么有价值的基础研究结果无法快速应用于人类的动脉粥样硬化的临床试验研究。
关键词: 脂肪因子;脂联素;动脉粥样硬化;瘦素;脂肪组织
图形摘要
Current Drug Targets
Title:The Role of Adipocytokines in Atherogenesis and Atheroprogression
Volume: 16 Issue: 4
Author(s): Federico Carbone, Francois Mach and Fabrizio Montecucco
Affiliation:
关键词: 脂肪因子;脂联素;动脉粥样硬化;瘦素;脂肪组织
摘要: Research investigations on adipose tissue were focused for several decades on its “storage” function. Emerging evidence unveiled adipose tissue as an endocrine organ releasing a several mediators termed as adipokines. Adipokine-mediated functions include both physiological and pathophysiological roles such as regulation of energy metabolism, immune response and vascular homeostasis, as well as inflammatory and metabolic diseases (i.e. atherogenesis, diabetes and obesity clustered in the concept of metabolic syndrome). A dysregulation of adipokine levels has been also suggested as a potential common mechanism underlying these disorders. For instance, an unbalance between pro- and anti-inflammatory adipokines was positively associated with traditional risk factors (dyslipidaemia, hypertension, insulin resistance) in obesity, diabetes and atherogenesis. Adipokine-mediated activities particularly affected endothelial dysfunction/activation and intraplaque inflammation/vulnerability. The purpose of this narrative review is to provide an overview on the role of adipokines in atherogenesis. Evidence from basic research studies about adipokine-induced regulation of vascular and immune cell subsets will be discussed. Finally, conflicting results from clinical trials we be reported, with an attempt to better understand the reason why promising basic research results did not allow a speedy “into human” translation for clinical management of atherogenesis.
Export Options
About this article
Cite this article as:
Federico Carbone, Francois Mach and Fabrizio Montecucco , The Role of Adipocytokines in Atherogenesis and Atheroprogression, Current Drug Targets 2015; 16 (4) . https://dx.doi.org/10.2174/1389450115666141109213439
DOI https://dx.doi.org/10.2174/1389450115666141109213439 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Central Blood Pressure and Prediction of Cardiovascular Events
Current Hypertension Reviews The Location of Vascular Flap is Related with Daily Activity Patterns in Non-traumatic Acute Aortic Syndrome in a Chinese Population
Current Signal Transduction Therapy Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies
Current Medicinal Chemistry Role of miRNAs in Muscle Stem Cell Biology: Proliferation, Differentiation and Death
Current Pharmaceutical Design Commercially Available, FDA-approved Epigenetic Modifiers As Therapeutic Agents in Bacterial Infection
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) APE1/Ref-1Role in Redox Signaling: Translational Applications of Targeting the Redox Function of the DNA Repair/Redox Protein APE1/Ref-1
Current Molecular Pharmacology The Ryanodine Receptor: A Pivotal Ca2+ Regulatory Protein and Potential Therapeutic Drug Target
Current Drug Targets Improving Red Blood Cell K-Uptake and its Impact on O2/CO2 Exchange, and NO-Generation in Microvascular CHD: A Novel Therapeutic Approach
Recent Patents on Cardiovascular Drug Discovery Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions
Current Medicinal Chemistry Obesity-Associated Hypertension in Childhood: A New Epidemic Problem
Current Hypertension Reviews Sleep Apnea: an Underestimated Cause of Resistant Hypertension
Current Hypertension Reviews Mechanisms of Thrombosis, Available Treatments and Management Challenges Presented by Thromboangiitis Obliterans
Current Medicinal Chemistry Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein 1: Recent Developments Concerning Substrates and Inhibitors of a Promising Therapeutic Target
Current Medicinal Chemistry Inflammatory Markers Associated With Diabetes Mellitus – Old and New Players
Current Pharmaceutical Design Subject Index To Volume 7
Current Drug Targets Hormone Replacement Therapy in Rheumatoid Arthritis
Current Rheumatology Reviews Virtual Screening Against Obesity
Current Medicinal Chemistry Docosahexaenoic Acid and Membrane Lipid Domains
Current Organic Chemistry Lipids and Non-Cardiac Vascular Disease: A Lecture Overview
Current Vascular Pharmacology The Critical Roles of HSC70 in Physiological and Pathological Processes
Current Pharmaceutical Design